Ignyta, Inc.
Records under this name other than the patents Ignyta, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,604,994 | Thienopyrimidine Inhibitors of Atypical Protein Kinase C now held by Windtree Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| US 9,896,446 | Azaquinazoline Inhibitors of Atypical Protein Kinase C now held by Windtree Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| US 10,414,763 | Azaquinazoline Inhibitors Of Atypical Protein Kinase C now held by Windtree Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| US 9,914,730 | Azaquinazoline Inhibitors of Atypical Protein Kinase C now held by Windtree Therapeutics, Inc. In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 10,869,864 | Combinations for the Treatment of Cancer Lapsed on the fee record Ended Dec 22, 2024 · High confidence | Lapsed on the fee record | Ended Dec 22, 2024 | High confidence |
| US 10,799,503 | Methods for the Treatment of Cancer Lapsed on the fee record Ended Oct 13, 2024 · High confidence | Lapsed on the fee record | Ended Oct 13, 2024 | High confidence |
| US 10,028,956 | METHODS OF TREATING VARIOUS CANCERS USING AN AXL/cMET INHIBITOR IN COMBINATION WITH OTHER AGENTS Lapsed on the fee record Ended Jul 24, 2022 · High confidence | Lapsed on the fee record | Ended Jul 24, 2022 | High confidence |
| US 10,017,496 | Uracil Derivatives as Axl and C-Met Kinase Inhibitors Lapsed on the fee record Ended Jul 10, 2022 · High confidence | Lapsed on the fee record | Ended Jul 10, 2022 | High confidence |
| US 9,987,281 | Solid State Forms of a Quinazoline Derivative and Its Use as a Braf Inhibitor Lapsed on the fee record Ended Jun 5, 2022 · High confidence | Lapsed on the fee record | Ended Jun 5, 2022 | High confidence |
| US 9,913,827 | Bendamustine Derivatives and Methods of Using Same Lapsed on the fee record Ended Mar 13, 2022 · High confidence | Lapsed on the fee record | Ended Mar 13, 2022 | High confidence |